Blog articles

Polycystic kidney disease and genomic testing
We explore genomics’ role in the cause, diagnosis and treatment of a complex kidney condition

NICE approves RNAi therapy for porphyria
This week, we look at the latest gene silencing treatment approved by NICE – this time for an acute form of porphyria

World-first study shows WGS improves diagnostic journey
Impressive results make the case for the adoption of whole genome sequencing as "the genetic test of choice for rare disease patients"

Genes, hormones and blood pressure
This week, we explore genomics’ role in primary aldosteronism – a hormone disorder that leads to high blood pressure

GEP fellow publishes RNA splicing study
Jamie Ellingford and his co-authors explore the potential of computational tools to help us learn more about the messages our genes create

Screening the healthy for monogenic variants
As the NHS moves towards a preventative healthcare strategy, will genomic screening for healthy people become more common?

Parkinson's disease: understanding the cause
In light of new research, we explore the role genes and their products can play in the onset of Parkinson’s disease

NHS targets better diabetes care with genomic testing
New initiative aims to find thousands of people with a rare, inherited form of diabetes

Newborn screening: time for a genomic approach?
This week, we explore how genomics could help expand the newborn screening programme to test for many more genetic conditions

Trial underway for hATTR therapy
The novel ‘one off’ treatment could change the lives of those living with the condition

Developmental disorder variants found in non-coding genome
This week, we explore new findings that link variants in the non-coding region of the genome to developmental disorders